Brain in flames – animal models of psychosis: utility and limitations

References

• WatanabeYSomeyaTNawaHCytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal modelsPsychiatry Clin Neurosci201064321723010.1111/j.1440-1819.2010.02094.x20602722
   PubMed Web of Science ®Google Scholar
• HorváthSMirnicsKImmune system disturbances in schizophreniaBiol Psychiatry201475431632310.1016/j.biopsych.2013.06.01023890736
   PubMed Web of Science ®Google Scholar
• LeuchtSBarnesTRKisslingWEngelRRCorrellCKaneJMRelapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trialsAm J Psychiatry200316071209122212832232
   PubMed Web of Science ®Google Scholar
• KeefeRSBilderRMDavisSMNeurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE TrialArch Gen Psychiatry200764663364710.1001/archpsyc.64.6.63317548746
   PubMed Web of Science ®Google Scholar
• LeshTANiendamTAMinzenbergMJCarterCSCognitive control deficits in schizophrenia: mechanisms and meaningNeuropsychopharmacology201136131633810.1038/npp.2010.15620844478
   PubMed Web of Science ®Google Scholar
• BuckleyPFStahlSMPharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?Acta Psychiatr Scand200711529310010.1111/j.1600-0447.2007.00992.x17244172
   PubMed Web of Science ®Google Scholar
• UçokAGaebelWSide effects of atypical antipsychotics: a brief overviewWorld Psychiatry200871586218458771
   PubMed Web of Science ®Google Scholar
• MuenchJHamerAMAdverse effects of antipsychotic medicationsAm Fam Physician201081561762220187598
   PubMed Web of Science ®Google Scholar
• PakpoorJAgiusMA review of the adverse side effects associated with antipsychotics as related to their efficacyPsychiatr Danub201426Suppl 127328425413553
   PubMedGoogle Scholar
• ChaudhryIBHallakJHusainNMinocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatmentJ Psychopharmacol20122691185119310.1177/026988111244494122526685
   PubMed Web of Science ®Google Scholar
• JhamnaniKShivakumarVKalmadySRaoNPVenkatasubramanianGSuccessful use of add-on minocycline for treatment of persistent negative symptoms in schizophreniaJ Neuropsychiatry Clin Neurosci2013251E06E0710.1176/appi.neuropsych.1112037623487204
   PubMed Web of Science ®Google Scholar
• LevkovitzYMendlovichSRiwkesSA double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophreniaJ Clin Psychiatry201071213814910.4088/JCP.08m04666yel19895780
   PubMed Web of Science ®Google Scholar
• FrickLRWilliamsKPittengerCMicroglial dysregulation in psychiatric diseaseClin Dev Immunol2013201360865410.1155/2013/60865423690824
   PubMedGoogle Scholar
• BernsteinH-GSteinerJGuestPCDobrowolnyHBogertsBGlial cells as key players in schizophrenia pathology: recent insights and concepts of therapySchizophr Res2015161141810.1016/j.schres.2014.03.03524948484
   PubMed Web of Science ®Google Scholar
• DoorduinJde VriesEFWillemsenATde GrootJCDierckxRAKleinHCNeuroinflammation in schizophrenia-related psychosis: a PET studyJ Nucl Med200950111801180710.2967/jnumed.109.06664719837763
   PubMed Web of Science ®Google Scholar
• Van BerckelBNBossongMGBoellaardRMicroglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography studyBiol Psychiatry200864982082210.1016/j.biopsych.2008.04.02518534557
   PubMed Web of Science ®Google Scholar
• ZhuFLiuYZhaoJZhengYMinocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of Granulocyte-Macrophage Colony-Stimulating Factor in adult ratsNeuroscience201426627528110.1016/j.neuroscience.2014.01.02124486961
   PubMed Web of Science ®Google Scholar
• JuckelGManitzMPBrüneMFriebeAHenekaMTWolfRJMicroglial activation in a neuroinflammational animal model of schizophrenia – a pilot studySchizophr Res20111311–39610010.1016/j.schres.2011.06.01821752601
   PubMed Web of Science ®Google Scholar
• MatteiDDjodari-IraniAHadarRMinocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophreniaBrain Behav Immun20143817518410.1016/j.bbi.2014.01.01924509090
   PubMed Web of Science ®Google Scholar
• ZhangLZhaoJProfile of minocycline and its potential in the treatment of schizophreniaNeuropsychiatr Dis Treat2014101103111110.2147/NDT.S6423624971013
   PubMed Web of Science ®Google Scholar
• GonzálezJCEgeaJDel Carmen GodinoMNeuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neuronsEur J Neurosci20072692481249510.1111/j.1460-9568.2007.05873.x17986028
   PubMed Web of Science ®Google Scholar
• WillnerPValidation criteria for animal models of human mental disorders: learned helplessness as a paradigm caseProg Neuropsychopharmacol Biol Psychiatry19861066776903809518
   PubMed Web of Science ®Google Scholar
• SmithCLBoltonANguyenGGenomic and epigenomic instability, fragile sites, schizophrenia and autismCurr Genomics201011644746910.2174/13892021079317600121358990
   PubMed Web of Science ®Google Scholar
• NetworkPPsychiatric genome-wide association study analyses implicate neuronal, immune and histone pathwaysNat Neurosci201518219920910.1038/nn.392225599223
   PubMed Web of Science ®Google Scholar
• Van OsJRuttenBPPoultonRGene-environment interactions in schizophrenia: review of epidemiological findings and future directionsSchizophr Bull20083461066108210.1093/schbul/sbn11718791076
   PubMed Web of Science ®Google Scholar
• MiyamotoYNittaABehavioral phenotypes for negative symptoms in animal models of schizophreniaJ Pharmacol Sci2014126431032010.1254/jphs.14R02CR25409784
   PubMed Web of Science ®Google Scholar
• van den BuuseMModeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsSchizophr Bull201036224627010.1093/schbul/sbp13219900963
   PubMed Web of Science ®Google Scholar
• KruegerDHowellJHebertBOlaussonPTaylorJNairnAAssessment of cognitive function in the heterozygous reeler mousePsychopharmacology (Berl)200618919510410.1007/s00213-006-0530-016977475
   PubMed Web of Science ®Google Scholar
• SeshadriSKamiyaAYokotaYDisrupted-in-schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascadeProc Natl Acad Sci U S A2010107125622562710.1073/pnas.090928410720212127
   PubMed Web of Science ®Google Scholar
• Jaaro-PeledHAyhanYPletnikovMVSawaAReview of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic modelsSchizophr Bull201036230131310.1093/schbul/sbp13319903746
   PubMed Web of Science ®Google Scholar
• HarveyLBoksaPA stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancyNeuropharmacology20126241767177610.1016/j.neuropharm.2011.11.02222178614
   PubMed Web of Science ®Google Scholar
• RatnayakeUQuinnTACastillo-MelendezMDickinsonHWalkerDWBehaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viral-mimetic Poly I:C at mid-pregnancyBrain Behav Immun20122681288129910.1016/j.bbi.2012.08.01122960545
   PubMed Web of Science ®Google Scholar
• TangBJiaHKastRJThomasEAEpigenetic changes at gene promoters in response to immune activation in uteroBrain Behav Immun201330216817510.1016/j.bbi.2013.01.08623402795
   PubMed Web of Science ®Google Scholar
• MarsmanAVan Den HeuvelMPKlompDWKahnRSLuijtenPRHulshoff PolHEGlutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studiesSchizophr Bull201339112012910.1093/schbul/sbr06921746807
   PubMed Web of Science ®Google Scholar
• HomayounHMoghaddamBNMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neuronsJ Neurosci20072743114961150010.1523/JNEUROSCI.2213-07.200717959792
   PubMed Web of Science ®Google Scholar
• AnticevicACorlettPRColeMWN-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophreniaBiol Psychiatry201577656958010.1016/j.biopsych.2014.07.02225281999
   PubMed Web of Science ®Google Scholar
• BondiCMatthewsMMoghaddamBGlutamatergic animal models of schizophreniaCurr Pharm Des201218121593160422280432
   PubMed Web of Science ®Google Scholar
• MoghaddamBJacksonMEGlutamatergic animal models of schizophreniaAnn N Y Acad Sci20031003113113710.1196/annals.1300.06514684441
   PubMed Web of Science ®Google Scholar
• HouYZhangHXieGNeuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in miceProg Neuropsychopharmacol Biol Psychiatry20134510711610.1016/j.pnpbp.2013.04.00623603358
   PubMed Web of Science ®Google Scholar
• MonteASde SouzaGCMcIntyreRSPrevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathwaysJ Psychopharmacol201327111032104310.1177/026988111350350624045882
   PubMed Web of Science ®Google Scholar
• BeckerAPetersBSchroederHMannTHuetherGGreckschGKetamine-induced changes in rat behaviour: a possible animal model of schizophreniaProg Neuropsychopharmacol Biol Psychiatry200327468770010.1016/S0278-5846(03)00080-012787858
   PubMed Web of Science ®Google Scholar
• SilvestreJSNadalRPallarésMFerréNAcute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar ratsDepress Anxiety199751293310.1002/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-09250438
   PubMedGoogle Scholar
• ChindoBAAdzuBYahayaTAGamanielKSKetamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophreniaProg Neuropsychopharmacol Biol Psychiatry201238231031610.1016/j.pnpbp.2012.04.01822561603
   PubMed Web of Science ®Google Scholar
• ZhuSWangHShiRChronic phencyclidine induces inflammatory responses and activates GSK3β in miceNeurochem Res201439122385239310.1007/s11064-014-1441-925270429
   PubMed Web of Science ®Google Scholar
• NakkiRNickolenkoJChangJSagarSMSharpFRHaloperidol prevents ketamine- and phencyclidine-induced hsp70 protein expression but not microglial activationExp Neurol199613722342418635538
   PubMed Web of Science ®Google Scholar
• NodaYYamadaKFurukawaHNabeshimaTEnhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophreniaBr J Pharmacol1995116253125378581295
   PubMed Web of Science ®Google Scholar
• SchroederUSchroederHSchweglerHSabelBANeuroleptics ameliorate phencyclidine-induced impairments of short-term memoryBr J Pharmacol2000130334010.1038/sj.bjp.070317110780995
   PubMed Web of Science ®Google Scholar
• FujitaYIshimaTKunitachiSPhencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocyclineProg Neuropsychopharmacol Biol Psychiatry200832233633910.1016/j.pnpbp.2007.08.03117884273
   PubMed Web of Science ®Google Scholar
• Sams-DoddFPhencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophreniaBehav Pharmacol19967132311224390
   PubMed Web of Science ®Google Scholar
• Sams-DoddFEffect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction testBehav Pharmacol199782–31962159833015
   PubMed Web of Science ®Google Scholar
• NodaANodaYKameiHPhencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma1 receptorsNeuropsychopharmacology200124445146010.1016/S0893-133X(00)00192-511182540
   PubMed Web of Science ®Google Scholar
• FelliniLKumarGGibbsSStecklerTTalposJRe-evaluating the PCP challenge as a pre-clinical model of impaired cognitive flexibility in schizophreniaEur Neuropsychopharmacol201424111836184910.1016/j.euroneuro.2014.08.01225300235
   PubMed Web of Science ®Google Scholar
• BrownJWRueterLEZhangMPredictive validity of a MK-801- induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinicallyProg Neuropsychopharmacol Biol Psychiatry201449536210.1016/j.pnpbp.2013.11.00824269664
   PubMed Web of Science ®Google Scholar
• Gaisler-SalomonIWeinerISystemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidolPsychopharmacology (Berl)2003166433334210.1007/s00213-002-1311-z12599023
   PubMed Web of Science ®Google Scholar
• RungJPCarlssonARyden MarkinhuhtaKCarlssonML(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophreniaProg Neuropsychopharmacol Biol Psychiatry200529582783210.1016/j.pnpbp.2005.03.00415916843
   PubMed Web of Science ®Google Scholar
• RungJPCarlssonAMarkinhuhtaKRCarlssonMLThe dopaminergic stabilizers (−)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in ratsProg Neuropsychopharmacol Biol Psychiatry200529583383910.1016/j.pnpbp.2005.03.00315913873
   PubMed Web of Science ®Google Scholar
• YoshimiNFutamuraTHashimotoKImprovement of dizocilpine-induced social recognition de fi cits in mice by brexpiprazole, a novel serotonin – dopamine activity modulatorEur Neuropsychopharmacol201525335636410.1016/j.euroneuro.2014.12.01425600995
   PubMed Web of Science ®Google Scholar
• LevinEDBettegowdaCWeaverTChristopherNCNicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm mazePharmacol Biochem Behav199861333534010.1016/S0091-3057(98)00109-99768569
   PubMed Web of Science ®Google Scholar
• Bubeníková-ValesováVHorácekJVrajováMHöschlCModels of schizophrenia in humans and animals based on inhibition of NMDA receptorsNeurosci Biobehav Rev20083251014102310.1016/j.neubiorev.2008.03.01218471877
   PubMed Web of Science ®Google Scholar
• HorvathZCCzopfJBuzsakiGMK-801-induced neuronal damage in ratsBrain Res199775321811959125402
   PubMed Web of Science ®Google Scholar
• LevkovitzYLeviUBrawYCohenHMinocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophreniaBrain Res2007115415416210.1016/j.brainres.2007.03.08017488642
   PubMed Web of Science ®Google Scholar
• KrausRLPasiecznyRLariosa-WillinghamKTurnerMSJiangATraugerJWAntioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activityJ Neurochem20059481982710.1111/j.1471-4159.2005.03219.x16033424
   PubMed Web of Science ®Google Scholar
• NikodemovaMWattersJJJacksonSJYangSKDuncanIDMinocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC) alpha/betaIIJ Biol Chem200728220152081521610.1074/jbc.M61190720017395590
   PubMed Web of Science ®Google Scholar
• KobayashiKImagamaSOhgomoriTMinocycline selectively inhibits M1 polarization of microgliaCell Death Dis201343e52510.1038/cddis.2013.5423470532
   PubMed Web of Science ®Google Scholar
• FixASHornJWWightmanKANeuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortexExp Neurol199312320421510.1006/exnr.1993.11538405286
   PubMed Web of Science ®Google Scholar
• ZhangLShirayamaYIyoMHashimotoKMinocycline attenuates hyper-locomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpineNeuropsychopharmacology20073292004201010.1038/sj.npp.130131317228338
   PubMed Web of Science ®Google Scholar
• ZhangXYChenD-CTanY-LThe interplay between BDNF and oxidative stress in chronic schizophreniaPsychoneuroendocrinology20155120120810.1016/j.psyneuen.2014.09.02925462893
   PubMed Web of Science ®Google Scholar
• BoskovicMVovkTKores PlesnicarBGrabnarIOxidative stress in schizophreniaCurr Neuropharmacol20119230131210.2174/15701591179559659522131939
   PubMed Web of Science ®Google Scholar
• LipskaBKHalimNDSegalPNWeinbergerDREffects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult ratJ Neurosci200222728352842 doi: 2002619511923448
   PubMed Web of Science ®Google Scholar
• LipskaBKJaskiwGEChrapustaSKaroumFWeinbergerDRIbotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the ratBrain Res19925851–21610.1016/0006-8993(92)91184-G1511295
   PubMed Web of Science ®Google Scholar
• LipskaBKWeinbergerDRA neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampusNeurotox Res200245–646947510.1080/102984202100002208912754160
   PubMed Web of Science ®Google Scholar
• TsengK-YLewisBLLipskaBKO’DonnellPPost-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophreniaBiol Psychiatry200762773073810.1016/j.biopsych.2006.10.01217207473
   PubMed Web of Science ®Google Scholar
• FelederCTsengKYCalhoonGGO’DonnellPNeonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult ratsBiol Psychiatry201067438639210.1016/j.biopsych.2009.09.02819914600
   PubMed Web of Science ®Google Scholar
• LipskaBWeinbergerDA neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampusNeurotox Res200245–646947510.1080/102984202100002208912754160
   PubMed Web of Science ®Google Scholar
• TsengKYO’DonnellPDopamine modulation of prefrontal cortical interneurons changes during adolescenceCereb Cortex20071751235124010.1093/cercor/bhl03416818475
   PubMed Web of Science ®Google Scholar
• WeinbergerDRLipskaBKCortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common groundSchizophr Res1995168711010.1016/0920-9964(95)00013-C7577773
   PubMed Web of Science ®Google Scholar
• AlquicerGSilva-GómezABPeraltaFFloresGNeonatal ventral hippocampus lesion alters the dopamine content in the limbic regions in postpubertal ratsInt J Dev Neurosci200422210311110.1016/j.ijdevneu.2003.12.00315036385
   PubMed Web of Science ®Google Scholar
• FloresGBarbeauDQuirionRSrivastavaLKDecreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampusJ Neurosci1996166202020268604046
   PubMed Web of Science ®Google Scholar
• FloresGWoodGKLiangJJQuirionRSrivastavaLKEnhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortexJ Neurosci19961622736673758929443
   PubMed Web of Science ®Google Scholar
• SchroederHGreckschGBeckerAHoelltVBogertsBAlterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesionPsychopharmacology (Berl)1999145616610.1007/s00213005103210445373
   PubMed Web of Science ®Google Scholar
• FrançoisJFerrandonAKoningEAngstM-JSandnerGNehligASelective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned ratsInt J Neuropsychopharmacol2009121097111010.1017/S146114570900998519267957
   PubMed Web of Science ®Google Scholar
• TsengKYLewisBLHashimotoTA neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneuronsJ Neurosci20082848126911269910.1523/JNEUROSCI.4166-08.200819036962
   PubMed Web of Science ®Google Scholar
• BenesFMBerrettaSGABAergic interneurons: implications for understanding schizophrenia and bipolar disorderNeuropsychopharmacology2001250112710.1016/S0893-133X(01)00225-111377916
   PubMed Web of Science ®Google Scholar
• FloresGAlquicerGSilva-GómezABAlterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampusNeuroscience200513346347010.1016/j.neuroscience.2005.02.02115878241
   PubMed Web of Science ®Google Scholar
• BringasMEMorales-MedinaJCFlores-VivaldoYClozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus ratNeuropharmacology20126241848185710.1016/j.neuropharm.2011.12.00822207157
   PubMed Web of Science ®Google Scholar
• HoriTSubramaniamSSrivastavaLKQuirionRBehavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesionsNeuropharmacology2000392478249110.1016/S0028-3908(00)00059-910974332
   PubMed Web of Science ®Google Scholar
• NaertAGantoisILaeremansABehavioural alterations relevant to developmental brain disorders in mice with neonatally induced ventral hippocampal lesionsBrain Res Bull201394718110.1016/j.brainresbull.2013.01.00823357176
   PubMed Web of Science ®Google Scholar
• RueterLEBallardMEGallagherKBBassoAMCurzonPKohlhaasKLChronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophreniaPsychopharmacology (Berl)20041763–431231910.1007/s00213-004-1897-415179541
   PubMed Web of Science ®Google Scholar
• Le PenGKewJAlberatiDBorroniEHeitzMPMoreauJLPrepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitorBiol Psychiatry200354031162117010.1016/S0006-3223(03)00374-314643083
   PubMed Web of Science ®Google Scholar
• BeckerAGreckschGHaloperidol and clozapine affect social behaviour in rats postnatally lesioned in the ventral hippocampusPharmacol Biochem Behav20037611810.1016/S0091-3057(03)00139-413679211
   PubMed Web of Science ®Google Scholar
• Le PenGGrottickAJHigginsGAMartinJRJenckFMoreauJLSpatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophreniaBehav Pharmacol2000113–425726811103880
   PubMed Web of Science ®Google Scholar
• BeningerRJTuerkeKJForsythJKNeonatal ventral hippocampal lesions in male and female rats: effects on water maze, locomotor activity, plus-maze and prefrontal cortical GABA and glutamate release in adulthoodBehav Brain Res2009202219820910.1016/j.bbr.2009.03.04419463702
   PubMed Web of Science ®Google Scholar
• LecourtierLAntalM-CCosquerBIntact neurobehavioral development and dramatic impairments of procedural-like memory following neonatal ventral hippocampal lesion in ratsNeuroscience201220711012310.1016/j.neuroscience.2012.01.04022322113
   PubMed Web of Science ®Google Scholar
• LipskaBWeinbergerDSubchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damageNeuropsychopharmacology19941031992057916917
   PubMed Web of Science ®Google Scholar
• Le PenGMoreauJLDisruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidolNeuropsychopharmacology200227111110.1016/S0893-133X(01)00383-912062902
   PubMed Web of Science ®Google Scholar
• LevinEDChristopherNCEffects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophreniaProg Neuropsychopharmacol Biol Psychiatry200630222322910.1016/j.pnpbp.2005.10.01816356617
   PubMed Web of Science ®Google Scholar
• LipskaBKUsing animal models to test a neurodevelopmental hypothesis of schizophreniaJ Psychiatry Neurosci200429428228615309044
   PubMed Web of Science ®Google Scholar
• Drouin-OuelletJBrownellALSaint-PierreMNeuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesionsGlia201159218819910.1002/glia.2108621125661
   PubMed Web of Science ®Google Scholar
• RaoJSKimH-WHarryGJRapoportSIReeseEAIncreased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patientsSchizophr Res20131471243110.1016/j.schres.2013.02.01723566496
   PubMed Web of Science ®Google Scholar
• SteinerJBielauHBrischRImmunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicideJ Psychiatr Res200842215115710.1016/j.jpsychires.2006.10.01317174336
   PubMed Web of Science ®Google Scholar
• MonjiAKatoTAMizoguchiYNeuroinflammation in schizophrenia especially focused on the role of microgliaProg Neuropsychopharmacol Biol Psychiatry20134211512110.1016/j.pnpbp.2011.12.00222192886
   PubMed Web of Science ®Google Scholar
• ZhuFZhengYDingY-QMinocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in ratsPLoS One201494e9396610.1371/journal.pone.009396624705495
   PubMed Web of Science ®Google Scholar
• BrownASEpidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autismDev Neurobiol2012721272127610.1002/dneu.2202422488761
   PubMed Web of Science ®Google Scholar
• MeyerUFeldonJEpidemiology-driven neurodevelopmental animal models of schizophreniaProg Neurobiol201090328532610.1016/j.pneurobio.2009.10.01819857543
   PubMed Web of Science ®Google Scholar
• KneelandREFatemiSHViral infection, inflammation and schizophreniaProg Neuropsychopharmacol Biol Psychiatry201342354810.1016/j.pnpbp.2012.02.00122349576
   PubMed Web of Science ®Google Scholar
• FatemiSHFolsomTDReutimanTJAbnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in miceSchizophr Res20091121–3465310.1016/j.schres.2009.04.01419487109
   PubMed Web of Science ®Google Scholar
• MeyerUPrenatal poly(i:C) exposure and other developmental immune activation models in rodent systemsBiol Psychiatry201475430731510.1016/j.biopsych.2013.07.01123938317
   PubMed Web of Science ®Google Scholar
• TakedaKAkiraSToll-like receptors in innate immunityInt Immunol200517111410.1093/intimm/dxh18615585605
   PubMed Web of Science ®Google Scholar
• LiQCheungCWeiRPrenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse modelPLoS One200947e635410.1371/journal.pone.000635419629183
   PubMed Web of Science ®Google Scholar
• PiontkewitzYAradMWeinerIAbnormal trajectories of neurodevelopment and behavior following in utero insult in the ratBiol Psychiatry201170984285110.1016/j.biopsych.2011.06.00721816387
   PubMed Web of Science ®Google Scholar
• PiontkewitzYAradMWeinerIRisperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophreniaSchizophr Bull20113761257126910.1093/schbul/sbq04020439320
   PubMed Web of Science ®Google Scholar
• PiontkewitzYAssafYWeinerIClozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophreniaBiol Psychiatry200966111038104610.1016/j.biopsych.2009.07.00519726031
   PubMed Web of Science ®Google Scholar
• MeyerUNyffelerMYeeBKKnueselIFeldonJAdult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in miceBrain Behav Immun200822446948610.1016/j.bbi.2007.09.01218023140
   PubMed Web of Science ®Google Scholar
• MeyerUNyffelerMEnglerAThe time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathologyJ Neurosci200626184752476210.1523/JNEUROSCI.0099-06.200616672647
   PubMed Web of Science ®Google Scholar
• IbiDNagaiTKitaharaYNeonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthoodNeurosci Res200964329730510.1016/j.neures.2009.03.01519447299
   PubMed Web of Science ®Google Scholar
• ZuckermanLRehaviMNachmanRWeinerIImmune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophreniaNeuropsychopharmacology200328101778178910.1038/sj.npp.130024812865897
   PubMed Web of Science ®Google Scholar
• OzawaKHashimotoKKishimotoTShimizuEIshikuraHIyoMImmune activation during pregnancy in mice leads to dopaminergic hyper-function and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophreniaBiol Psychiatry200659654655410.1016/j.biopsych.2005.07.03116256957
   PubMed Web of Science ®Google Scholar
• TseMTPiantadosiPTFlorescoSBPrefrontal cortical gamma-aminobutyric acid transmission and cognitive function: drawing links to schizophrenia from preclinical researchBiol Psychiatry201411110.1016/j.biopsych.2014.09.007.
   Web of Science ®Google Scholar
• NyffelerMMeyerUYeeBKFeldonJKnueselIMaternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophreniaNeuroscience20061431516210.1016/j.neuroscience.2006.07.02917045750
   PubMed Web of Science ®Google Scholar
• RichettoJCalabreseFMeyerURivaMAPrenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in miceBrain Behav Immun20133319020010.1016/j.bbi.2013.07.00623876745
   PubMed Web of Science ®Google Scholar
• SoumiyaHFukumitsuHFurukawaSPrenatal immune challenge compromises development of upper-layer but not deeper-layer neurons of the mouse cerebral cortexJ Neurosci Res20118991342135010.1002/jnr.2263621674566
   PubMed Web of Science ®Google Scholar
• WinterCDjodari-IraniASohrRPrenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophreniaInt J Neuropsychopharmacol200912451352410.1017/S146114570800920618752727
   PubMed Web of Science ®Google Scholar
• BitanihirweBKPeleg-RaibsteinDMouttetFFeldonJMeyerULate prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophreniaNeuropsychopharmacology201035122462247810.1038/npp.2010.12920736993
   PubMed Web of Science ®Google Scholar
• RoenkerNLGudelskyGAhlbrandREffect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801Neurosci Lett2011500316717110.1016/j.neulet.2011.06.01121699956
   PubMed Web of Science ®Google Scholar
• HollowayTMorenoJLUmaliAPrenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune systemJ Neurosci20133331088109810.1523/JNEURO-SCI.2331-12.201323325246
   PubMed Web of Science ®Google Scholar
• DaltonVSVerdurandMWalkerAHodgsonDMZavitsanouKSynergistic effect between maternal infection and adolescent cannabinoid exposure on serotonin 5HT1A receptor binding in the hippocampus: testing the “two hit” hypothesis for the development of schizophreniaISRN Psychiatry201220121910.5402/2012/451865
   Google Scholar
• SelvarajSArnoneDCappaiAHowesOAlterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studiesNeurosci Biobehav Rev20144523324510.1016/j.neubiorev.2014.06.00524971825
   PubMed Web of Science ®Google Scholar
• DalackGWHealyDJMeador-WoodruffJHNicotine dependence in schizophrenia: clinical phenomena and laboratory findingsAm J Psychiatry199815511149015019812108
   PubMed Web of Science ®Google Scholar
• HoltDJHermanMMHydeTMEvidence for a deficit in cholinergic interneurons in the striatum in schizophreniaNeuroscience1999941213110.1016/S0306-4522(99)00279-110613493
   PubMed Web of Science ®Google Scholar
• OlincyAStevensKETreating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to menBiochem Pharmacol20077481192120110.1016/j.bcp.2007.07.01517714692
   PubMed Web of Science ®Google Scholar
• BermanJATalmageDARoleLWCholinergic circuits and signaling in the pathophysiology of schizophreniaInt Rev Neurobiol20077819322310.1016/S0074-7742(06)78007-217349862
   PubMed Web of Science ®Google Scholar
• MoneyTTScarrEUdawelaMTreating schizophrenia: novel targets for the cholinergic systemCNS Neurol Disord Drug Targets20109224125620053170
   PubMed Web of Science ®Google Scholar
• WuW-LAdamsCEStevensKEChowK-HFreedmanRPattersonPHThe interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspringBrain Behav Immun20154619220225683697
   PubMed Web of Science ®Google Scholar
• LiW-YChangY-CLeeLJLeeL-JPrenatal infection affects the neuronal architecture and cognitive function in adult miceDev Neurosci201436535937010.1159/00036238324942872
   PubMed Web of Science ®Google Scholar
• GlausierJRLewisDADendritic spine pathology in schizophreniaNeuroscience20132519010710.1016/j.neuroscience.2012.04.04422546337
   PubMed Web of Science ®Google Scholar
• NajjarSPearlmanDMNeuroinflammation and white matter pathology in schizophrenia: systematic reviewSchizophr Res2015161110211210.1016/j.schres.2014.04.04124948485
   PubMed Web of Science ®Google Scholar
• HagmannPJonassonLMaederPThiranJ-PWedeenVJMeuliRUnderstanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyondRadiographics200626Suppl 1S205S22310.1148/rg.26si06551017050517
   PubMed Web of Science ®Google Scholar
• Alvarado-AlanisPLeon-OrtizPReyes-MadrigalFAbnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysisSchizophr Res20151621–3142110.1016/j.schres.2015.01.01925620120
   PubMed Web of Science ®Google Scholar
• LiQCheungCWeiRVoxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancyNeuroimage20105211810.1016/j.neuroimage.2010.04.01520399275
   PubMed Web of Science ®Google Scholar
• DickersonDDBilkeyDKAberrant neural synchrony in the maternal immune activation model: using translatable measures to explore targeted interventionsFront Behav Neurosci201371221710.3389/fnbeh.2013.0021724409130
   PubMed Web of Science ®Google Scholar
• DickersonDDOvereemKAWolffARWilliamsJMAbrahamWCBilkeyDKAssociation of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophreniaTransl Psychiatry201447e41810.1038/tp.2014.6425072323
   PubMed Web of Science ®Google Scholar
• SmithSELiJGarbettKMirnicsKPattersonPHMaternal immune activation alters fetal brain development through interleukin-6J Neurosci20072740106951070210.1523/JNEUROSCI.2178-07.200717913903
   PubMed Web of Science ®Google Scholar
• KhanDFernandoPCicvaricALong-term effects of maternal immune activation on depression-like behavior in the mouseTransl Psychiatry20144e36310.1038/tp.2013.13224548878
   PubMed Web of Science ®Google Scholar
• ZhangZvan PraagHMaternal immune activation differentially impacts mature and adult-born hippocampal neurons in male miceBrain Behav Immun201545607010.1016/j.bbi.2014.10.01025449671
   PubMed Web of Science ®Google Scholar
• ZhangYCazakoffBNThaiCAHowlandJGPrenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, ratsNeuropharmacology20126231299130710.1016/j.neuropharm.2011.02.02221376064
   PubMed Web of Science ®Google Scholar
• HowlandJGCazakoffBNZhangYAltered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancyNeuroscience201220118419810.1016/j.neuroscience.2011.11.01122119062
   PubMed Web of Science ®Google Scholar
• KhanDFernandoPCicvaricALong-term effects of maternal immune activation on depression-like behavior in the mouseTransl Psychiatry20144e36310.1038/tp.2013.13224548878
   PubMed Web of Science ®Google Scholar
• MeyerUKnueselINyffelerMFeldonJChronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesisPsychopharmacology (Berl)2010208453154310.1007/s00213-009-1754-620041229
   PubMed Web of Science ®Google Scholar
• MissaultSVan den EyndeKVanden BergheWThe risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental modelBrain Behav Immun20144213814610.1016/j.bbi.2014.06.01324973728
   PubMed Web of Science ®Google Scholar
• Arrode-BrusésGBrusésJLMaternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brainJ Neuroinflammation2012918310.1186/1742-2094-9-8322546005
   PubMed Web of Science ®Google Scholar
• PrattLNiLPonzioNMJonakaitGMMaternal inflammation promotes fetal microglial activation and increased cholinergic expression in the fetal basal forebrain: role of interleukin-6Pediatr Res201374439340110.1038/pr.2013.12623877071
   PubMed Web of Science ®Google Scholar
• RatnayakeUQuinnTLaRosaDADickinsonHWalkerDWPrenatal exposure to the viral mimetic poly I:C alters fetal brain cytokine expression and postnatal behaviourDev Neurosci2014362839410.1159/00036220524863806
   PubMed Web of Science ®Google Scholar
• JackCSArbourNManusowJTLR signaling tailors innate immune responses in human microglia and astrocytesJ Immunol200517574320433016177072
   PubMed Web of Science ®Google Scholar
• KettenmannHKirchhoffFVerkhratskyAMicroglia: new roles for the synaptic stripperNeuron2013771101810.1016/j.neuron.2012.12.02323312512
   PubMed Web of Science ®Google Scholar
• CunninghamCLMartínez-CerdeñoVNoctorSCMicroglia regulate the number of neural precursor cells in the developing cerebral cortexJ Neurosci201333104216423310.1523/JNEUROSCI.3441-12.201323467340
   PubMed Web of Science ®Google Scholar
• GarayPAHsiaoEYPattersonPHMcallisterAKMaternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout developmentBrain Behav Immun201331546810.1016/j.bbi.2012.07.00822841693
   PubMed Web of Science ®Google Scholar
• Van den EyndeKMissaultSFransenEHypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophreniaBehav Brain Res201425817918610.1016/j.bbr.2013.10.00524129217
   PubMed Web of Science ®Google Scholar
• ZhuFZhengYLiuYZhangXZhaoJMinocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acidPsychiatry Res2014219368068610.1016/j.psychres.2014.06.04625042426
   PubMed Web of Science ®Google Scholar
• KellerWRKumLMWehringHJKoolaMMBuchananRWKellyDLA review of anti-inflammatory agents for symptoms of schizophreniaJ Psychopharmacol201327433734210.1177/026988111246708923151612
   PubMed Web of Science ®Google Scholar
• SommerIEvan WestrhenenRBegemannMJde WitteLDLeuchtSKahnRSEfficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an updateSchizophr Bull201440118119110.1093/schbul/sbt13924106335
   PubMed Web of Science ®Google Scholar
• PattersonPHModeling autistic features in animalsPediatr Res2011695344010.1203/PDR.0b013e318212b80f20940665
   PubMed Web of Science ®Google Scholar
• PattersonPHMaternal infection and immune involvement in autismTrends Mol Med201117738939410.1016/j.molmed.2011.03.00121482187
   PubMed Web of Science ®Google Scholar
• SuzukiKSugiharaGOuchiYMicroglial activation in young adults with autism spectrum disorderJAMA Psychiatry201370495810.1001/jamapsychiatry.2013.27223404112
   PubMed Web of Science ®Google Scholar
• RodriguezJIKernJKEvidence of microglial activation in autism and its possible role in brain underconnectivityNeuron Glia Biol201271910.1017/S1740925X12000142
   Google Scholar
• TheoharidesTCAthanassiouMPanagiotidouSDoyleRDysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disordersJ Neuroimmunol2015279333810.1016/j.jneuroim.2014.12.00325669997
   PubMed Web of Science ®Google Scholar
• BaharnooriMBhardwajSKSrivastavaLKEffect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspringPLoS One201381182310.1371/journal.pone.0054439
   Web of Science ®Google Scholar
• SantanaNMengodGArtigasFQuantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortexCereb Cortex200919484986010.1093/cercor/bhn13418689859
   PubMed Web of Science ®Google Scholar
• BorrellJVelaJMArévalo-MartinAMolina-HolgadoEGuazaCPrenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophreniaNeuropsychopharmacology200226220421510.1016/S0893-133X(01)00360-811790516
   PubMed Web of Science ®Google Scholar
• RomeroEAliCMolina-HolgadoECastellanoBGuazaCBorrellJNeurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychoticsNeuropsychopharmacology20073281791180410.1038/sj.npp.130129217180123
   PubMed Web of Science ®Google Scholar
• BaharnooriMBrakeWGSrivastavaLKPrenatal immune challenge induces developmental changes in the morphology of pyramidal neurons of the prefrontal cortex and hippocampus in ratsSchizophr Res200910719910910.1016/j.schres.2008.10.00319004618
   PubMed Web of Science ®Google Scholar
• GolanHMLevVHallakMSorokinYHuleihelMSpecific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancyNeuropharmacology200548690391710.1016/j.neuropharm.2004.12.02315829260
   PubMed Web of Science ®Google Scholar
• Basta-KaimAFijalKSlusarczykJPrenatal administration of lipopolysaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brainNeuroscience2015287789210.1016/j.neuroscience.2014.12.01325528062
   PubMed Web of Science ®Google Scholar
• WischhofLIrrsackEOsorioCKochMPrenatal LPS-exposure – a neurodevelopmental rat model of schizophrenia – differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspringProg Neuropsychopharmacol Biol Psychiatry201557173010.1016/j.pnpbp.2014.10.00425455585
   PubMed Web of Science ®Google Scholar
• LinY-LWangSPrenatal lipopolysaccharide exposure increases depression-like behaviors and reduces hippocampal neurogenesis in adult ratsBehav Brain Res2014259243410.1016/j.bbr.2013.10.03424177209
   PubMed Web of Science ®Google Scholar
• KirstenTBTaricanoMMaiorkaPCPalermo-NetoJBernardiMMPrenatal lipopolysaccharide reduces social behavior in male offspringNeuroimmunomodulation201017424025110.1159/00029004020203530
   PubMed Web of Science ®Google Scholar
• FoleyKAMacFabeDFVazAOssenkoppK-PKavaliersMSexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disordersInt J Dev Neurosci201439687810.1016/j.ijdevneu.2014.04.00124747144
   PubMed Web of Science ®Google Scholar
• HavaGVeredLYaelMMordechaiHMahoudHAlterations in behavior in adult offspring mice following maternal inflammation during pregnancyDev Psychobiol200648216216810.1002/dev.2011616489598
   PubMed Web of Science ®Google Scholar
• ChlodzinskaNGajerskaMBartkowskaKTurlejskiKDjavadianRLLipopolysaccharide injected to pregnant mice affects behavior of their offspring in adulthoodActa Neurobiol Exp (Wars)201171451952722237497
   PubMed Web of Science ®Google Scholar
• Basta-KaimABudziszewskaBLeskiewiczMHyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: effects of antipsychotic drugsEur J Pharmacol20116502–358659510.1016/j.ejphar.2010.09.08321034739
   PubMed Web of Science ®Google Scholar
• LinY-LLinS-YWangSPrenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stress-induced corticosterone responses in adult ratsBrain Behav Immun201226345946810.1016/j.bbi.2011.12.00322198119
   PubMed Web of Science ®Google Scholar
• Basta-kaimASzczêsnyELeoekiewiczMMaternal immune activation leads to age-related behavioral and immunological changes in male rat offspring – the effect of antipsychotic drugsPharmacol Rep20126461400141023406750
   PubMed Web of Science ®Google Scholar
• GraciarenaMDepinoAMPitossiFJPrenatal inflammation impairs adult neurogenesis and memory related behavior through persistent hippocampal TGFbeta1 downregulationBrain Behav Immun20102481301130910.1016/j.bbi.2010.06.00520600816
   PubMed Web of Science ®Google Scholar
• GraciarenaMRocaVMathieuPDepinoAMPitossiFJDifferential vulnerability of adult neurogenesis by adult and prenatal inflammation: role of TGF-beta1Brain Behav Immun201334172810.1016/j.bbi.2013.05.00723732461
   PubMed Web of Science ®Google Scholar
• BattistaDFerrariCCGageFHPitossiFJNeurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrusEur J Neurosci2006231839310.1111/j.1460-9568.2005.04539.x16420418
   PubMed Web of Science ®Google Scholar
• SierraAEncinasJMDeuderoJJMicroglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosisCell Stem Cell20107448349510.1016/j.stem.2010.08.01420887954
   PubMed Web of Science ®Google Scholar
• IbiDNagaiTKitaharaYNeonatal polyI:C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthoodNeurosci Res200964329730510.1016/j.neures.2009.03.01519447299
   PubMed Web of Science ®Google Scholar
• UrakuboAJarskogLFLiebermanJAGilmoreJHPrenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brainSchizophr Res200147273610.1016/S0920-9964(00)00032-311163542
   PubMed Web of Science ®Google Scholar
• AshdownHDumontYNgMPooleSBoksaPLuheshiGNThe role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophreniaMol Psychiatry200611475510.1038/sj.mp.400174816189509
   PubMed Web of Science ®Google Scholar
• MaynardTMSikichLLiebermanJALaMantiaASNeural development, cell-cell signaling, and the “two-hit” hypothesis of schizophreniaSchizophr Bull20012745747611596847
   PubMed Web of Science ®Google Scholar
• LipinaTVZaiCHlousekDRoderJCWongAHMaternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in miceJ Neurosci201333187654766610.1523/JNEUROSCI.0091-13.201323637159
   PubMed Web of Science ®Google Scholar
• GiovanoliSWeberLMeyerUSingle and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formationBrain Behav Immun201440485424859043
   PubMed Web of Science ®Google Scholar
• GiovanoliSEnglerHEnglerAStress in puberty unmasks latent neuropathological consequences of prenatal immune activation in miceScience201333961231095109923449593
   PubMed Web of Science ®Google Scholar
• DeslauriersJLaroucheASarretPGrignonSCombination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markersProg Neuropsychopharmacol Biol Psychiatry20134515616423697796
   PubMed Web of Science ®Google Scholar